Toward standardized outcome reporting in pneumonia: an overview of systematic reviews of antimicrobial therapy
International Journal of Clinical Pharmacy · 2025
DOI: 10.1007/s11096-025-02050-7 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Clinical Pharmacy, 2025. Verfasst von Hong Cao und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei Province, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Anti-Infective Agents, Outcome Assessment, Health Care, Pneumonia. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Pneumonia is a leading cause of morbidity and mortality worldwide, with community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP) representing the two most common subtypes. Antimicrobials are central to treatment; however, systematic reviews (SRs) evaluating their use have reported highly variable outcomes, limiting evidence synthesis and comparability. The development of a core outcome set (COS) may address this gap. AIM: To summarize the primary outcomes reported in SRs of antimicrobials for adult pneumonia and to construct an preliminary list of candidate outcomes to inform COS development. METHOD: A systematic search was performed in PubMed, Embase, Cochrane Library, CNKI, Wanfang Data, and China Science and Technology Journal Database from inception to December 2024. Eligible studies included SRs or meta-analyses that evaluated antimicrobial therapy in adults (≥ 18 years) with CAP or HAP. Two reviewers independently screened the studies, extracted data on the study characteristics, pneumonia type, severity assessment tools, and outcomes. The Corrected Covered Area (CCA) was calculated to quantify the overlap in primary outcome reporting. Outcomes were grouped by pneumonia type and severity and categorized into five domains following the COMET taxonomy. RESULTS: A total of 97 SRs were included. Twenty-one distinct primary outcomes were identified, with limited overlap. Mortality and clinical success were the most frequently reported outcomes, though inconsistently defined across studies. Significant variability was noted in the definitions and time points of outcomes, as well as in severity assessment tools. Registered SRs reported fewer outcomes than non-registered ones. CONCLUSION: There is considerable variation in primary outcome reporting in antimicrobial SRs for adult pneumonia. Mortality and clinical success are the most commonly reported outcomes, but their definitions lack consistency. Developing subtype- and severity-specific COS is crucial for standardizing outcome reporting and improving evidence synthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
- Office of Health Insurance Administration, Guizhou Provincial People's Hospital, No. 83 Zhongshandong Road, Guiyang, Guizhou Province, China.
- Department of Pharmacy, Guizhou Provincial People's Hospital, No. 83 Zhongshandong Road, Guiyang, Guizhou Province, China.
- Department of Health Services Management, Guizhou Medical University, Shansi Building, Huaxi College Town, Guiyang, Guizhou Province, China.
- Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Room 601, Novum PI 6, Hälsovägen 7, Huddinge, 14157, Stockholm, Sweden.
- Department of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, No. 20, Ximianqiao Hengjie, Jiangxi Street Subdistrict, Wuhou District, Chengdu City, Sichuan Province, China.
Zitieren
APA
Cao, H., Tan, S., Zhang, R., Zhao, H., Hu, L., Wang, J., Lan, J., Sun, S., Yang, Z., He, R., Zheng, W., Li, X., & Zhang, J. (2025). Toward standardized outcome reporting in pneumonia: an overview of systematic reviews of antimicrobial therapy. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-025-02050-7
Vancouver
Cao H, Tan S, Zhang R, Zhao H, Hu L, Wang J, et al. Toward standardized outcome reporting in pneumonia: an overview of systematic reviews of antimicrobial therapy. International Journal of Clinical Pharmacy. 2025. doi:10.1007/s11096-025-02050-7
BibTeX
@article{Cao2025,
author = {Cao, Hong and Tan, Songsong and Zhang, Rui and Zhao, Huaye and Hu, Linfang and Wang, Jiaxue and Lan, Junjie and Sun, Shuimei and Yang, Zhihao and He, Rui and Zheng, Wenyi and Li, Xiaosi and Zhang, Jiaxing},
title = {Toward standardized outcome reporting in pneumonia: an overview of systematic reviews of antimicrobial therapy},
journal = {International Journal of Clinical Pharmacy},
year = {2025},
doi = {10.1007/s11096-025-02050-7}
}
EUVIMED